NCT01903967View on ClinicalTrials.gov

Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)

CompletedOBSERVATIONAL

Enrollment

213

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Pituitary Tumors

Trial Locations (1)

69003

Hospices Civils de Lyon - Groupement Hospitalier Est, Lyon

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT01903967 - Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH) | Biotech Hunter | Biotech Hunter